<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>114</volume><submitter>Lin RJ</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>First described in 1972, idiopathic subglottic stenosis (iSGS) is a serious chronic orphan disease characterised by recurrent scarring of the subglottis. Although the cause is unknown, iSGS is almost exclusively restricted to Caucasian females typically in their fourth to sixth decade. However, given its rare incidence (1:400,000), understanding the clinical trajectory and molecular factors associated with iSGS disease development and prognosis has been difficult. In the current study we sought to unravel the pathogenesis of iSGS at the clinical, transcriptional, and genetic level in a prospective cohort.&lt;h4>Methods&lt;/h4>We prospectively enrolled 126 patients with iSGS, 104 controls, and 13 patients with traumatic SGS. Within this cohort, we profiled 114 human epiglottis </pubmed_abstract><journal>EBioMedicine</journal><pagination>105629</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11924928</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Cohort-level clinical trajectory and molecular landscape of idiopathic subglottic stenosis for precision laryngology-a study of the Canadian airways research (CARE) group.</pubmed_title><pmcid>PMC11924928</pmcid><pubmed_authors>MacInnis P</pubmed_authors><pubmed_authors>Inculet R</pubmed_authors><pubmed_authors>Zeng PY</pubmed_authors><pubmed_authors>Woo E</pubmed_authors><pubmed_authors>Fung K</pubmed_authors><pubmed_authors>Lin S</pubmed_authors><pubmed_authors>Ying S</pubmed_authors><pubmed_authors>Shaikh MH</pubmed_authors><pubmed_authors>Mymryk JS</pubmed_authors><pubmed_authors>Hu A</pubmed_authors><pubmed_authors>Lin RJ</pubmed_authors><pubmed_authors>Cecchini MJ</pubmed_authors><pubmed_authors>Zeng PYF</pubmed_authors><pubmed_authors>Al Jawhri M</pubmed_authors><pubmed_authors>Jarycki L</pubmed_authors><pubmed_authors>Khan H</pubmed_authors><pubmed_authors>Pan H</pubmed_authors><pubmed_authors>Anderson J</pubmed_authors><pubmed_authors>Nichols AC</pubmed_authors><pubmed_authors>Canadian Airways Research Group of the Canadian Society of Otolaryngology Collaborative Research Initiative</pubmed_authors><pubmed_authors>Karimi A</pubmed_authors><pubmed_authors>Barrett JW</pubmed_authors><pubmed_authors>Coburn B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cohort-level clinical trajectory and molecular landscape of idiopathic subglottic stenosis for precision laryngology-a study of the Canadian airways research (CARE) group.</name><description>&lt;h4>Background&lt;/h4>First described in 1972, idiopathic subglottic stenosis (iSGS) is a serious chronic orphan disease characterised by recurrent scarring of the subglottis. Although the cause is unknown, iSGS is almost exclusively restricted to Caucasian females typically in their fourth to sixth decade. However, given its rare incidence (1:400,000), understanding the clinical trajectory and molecular factors associated with iSGS disease development and prognosis has been difficult. In the current study we sought to unravel the pathogenesis of iSGS at the clinical, transcriptional, and genetic level in a prospective cohort.&lt;h4>Methods&lt;/h4>We prospectively enrolled 126 patients with iSGS, 104 controls, and 13 patients with traumatic SGS. Within this cohort, we profiled 114 human epiglottis </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2025-04-04T00:08:23.072Z</modification><creation>2025-04-04T00:08:23.072Z</creation></dates><accession>S-EPMC11924928</accession><cross_references><pubmed>40048847</pubmed><doi>10.1016/j.ebiom.2025.105629</doi></cross_references></HashMap>